| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/22/2023 | 29.09% | UBS | $210 → $200 | Maintains | Buy |
| 10/04/2023 | 11.66% | Raymond James | $222 → $173 | Maintains | Outperform |
| 09/18/2023 | 14.89% | Citigroup | $178 → $178 | Maintains | Neutral |
| 07/24/2023 | 43.29% | Raymond James | $239 → $222 | Maintains | Outperform |
| 04/24/2023 | -6.41% | Keefe, Bruyette & Woods | $160 → $145 | Maintains | Market Perform |
| 04/11/2023 | -14.15% | Goldman Sachs | $193 → $133 | Maintains | Sell |
| 04/10/2023 | -14.15% | Goldman Sachs | $193 → $133 | Maintains | Sell |
| 03/28/2023 | 0.05% | Citigroup | $200 → $155 | Maintains | Neutral |
| 03/16/2023 | 40.71% | Wolfe Research | → $218 | Upgrades | Peer Perform → Outperform |
| 03/03/2023 | 38.77% | JP Morgan | $214 → $215 | Maintains | Overweight |
| 02/01/2023 | — | Wolfe Research | Downgrades | Outperform → Peer Perform | |
| 01/27/2023 | 29.09% | Citigroup | → $200 | Initiates Coverage On | → Neutral |
| 01/20/2023 | 54.26% | Raymond James | $243 → $239 | Maintains | Outperform |
| 11/03/2022 | 56.85% | Raymond James | $267 → $243 | Maintains | Outperform |
| 10/20/2022 | 72.34% | Raymond James | $287 → $267 | Maintains | Outperform |
| 10/19/2022 | 10.37% | Goldman Sachs | $193 → $171 | Maintains | Sell |
| 09/21/2022 | 59.43% | UBS | $287 → $247 | Maintains | Buy |
| 08/04/2022 | 85.24% | Raymond James | $280 → $287 | Maintains | Outperform |
| 07/22/2022 | 80.73% | Raymond James | $295 → $280 | Maintains | Outperform |
| 04/26/2022 | 90.41% | Raymond James | $329 → $295 | Maintains | Outperform |
| 04/05/2022 | 40.06% | Goldman Sachs | → $217 | Initiates Coverage On | → Sell |
| 03/10/2022 | 116.23% | Wolfe Research | $461 → $335 | Maintains | Outperform |
| 01/21/2022 | 105.25% | Raymond James | $302 → $318 | Maintains | Outperform |
| 11/04/2021 | 94.93% | Raymond James | $282 → $302 | Maintains | Outperform |
| 10/22/2021 | 82.02% | Raymond James | $279 → $282 | Maintains | Outperform |
| 06/15/2021 | 114.29% | Wolfe Research | → $332 | Initiates Coverage On | → Outperform |
| 05/06/2021 | 41.35% | JP Morgan | $200 → $219 | Maintains | Overweight |
| 04/27/2021 | 27.8% | Raymond James | $186 → $198 | Maintains | Outperform |
| 01/22/2021 | 14.25% | Raymond James | $142 → $177 | Maintains | Outperform |
| 10/22/2020 | -10.28% | Raymond James | $144 → $139 | Maintains | Outperform |
| 10/08/2020 | — | Keefe, Bruyette & Woods | Downgrades | Outperform → Market Perform | |
| 08/11/2020 | -21.25% | UBS | $119 → $122 | Maintains | Buy |
| 07/29/2020 | -5.76% | Raymond James | $172 → $146 | Maintains | Outperform |
| 05/13/2020 | -23.19% | UBS | $188 → $119 | Maintains | Buy |
| 04/09/2020 | -14.8% | JP Morgan | $183 → $132 | Maintains | Overweight |
| 03/12/2020 | 18.12% | JP Morgan | $198 → $183 | Maintains | Overweight |
| 02/28/2020 | 21.35% | UBS | $185 → $188 | Maintains | Buy |
| 11/26/2019 | — | B of A Securities | Initiates Coverage On | → Neutral | |
| 11/08/2019 | 19.41% | UBS | $178 → $185 | Maintains | Buy |
| 08/12/2019 | 14.89% | UBS | $175 → $178 | Maintains | Buy |
| 07/30/2019 | 12.95% | UBS | $173 → $175 | Upgrades | Neutral → Buy |
| 07/17/2019 | — | JP Morgan | Initiates Coverage On | → Overweight | |
| 07/11/2019 | 16.18% | Compass Point | → $180 | Initiates Coverage On | → Buy |
| 05/10/2019 | 32.96% | Goldman Sachs | $183 → $206 | Upgrades | Neutral → Buy |
| 04/17/2019 | 15.54% | Keefe, Bruyette & Woods | → $179 | Upgrades | Market Perform → Outperform |
| 02/13/2019 | 21.35% | Raymond James | $178 → $188 | Maintains | Outperform |
| 01/03/2019 | — | B of A Securities | Downgrades | Buy → Underperform |
What is the target price for Jones Lang LaSalle (JLL)?
The latest price target for Jones Lang LaSalle (NYSE: JLL) was reported by UBS on November 22, 2023. The analyst firm set a price target for $200.00 expecting JLL to rise to within 12 months (a possible 29.09% upside). 13 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Jones Lang LaSalle (JLL)?
The latest analyst rating for Jones Lang LaSalle (NYSE: JLL) was provided by UBS, and Jones Lang LaSalle maintained their buy rating.
When is the next analyst rating going to be posted or updated for Jones Lang LaSalle (JLL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Jones Lang LaSalle, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Jones Lang LaSalle was filed on November 22, 2023 so you should expect the next rating to be made available sometime around November 22, 2024.
Is the Analyst Rating Jones Lang LaSalle (JLL) correct?
While ratings are subjective and will change, the latest Jones Lang LaSalle (JLL) rating was a maintained with a price target of $210.00 to $200.00. The current price Jones Lang LaSalle (JLL) is trading at is $154.93, which is out of the analyst's predicted range.